Back to companies

Viela Bio Inc: Overview

Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $125 per month (billed Annually)
Signup to View Free Sample

Viela Bio Inc (Viela) is a biotechnology company. It develops novel therapies for treatment of autoimmune inflammatory diseases. The company’s pipeline products include Inebilizumab, a humanized monoclonal antibody; VIB4920, a fusion protein designed to bind to CD40L on activated T cells, blocking their interaction with CD40-expressing B cells; VIB7734, a novel treatment for autoimmune diseases caused by the overproduction of type I interferons and other cytokines secreted by a type of dendritic cell called pDCs. Its products are developed for treatment of myasthenia gravis, IgG4-related disease, Sjogren’s syndrome and kidney transplant rejection. Viela is headquartered in Gaithersburg, Maryland, the US.

Headquarters United States of America

Address 1 Medimmune Way, Area Two, Gaithersburg, Maryland, 20878


Telephone 1 240 5580038

No of Employees 170

Industry Pharmaceuticals and Healthcare

Revenue (2020) $11.7M

   

   

Explore premium data & analytics

19+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Viela Bio Inc’s relevant decision makers and contact details.

18+

Catalyst Calendar

Proactively evaluate Viela Bio Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

14+

Clinical Trials

Determine Viela Bio Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

6

Pipeline Drugs

Identify which of Viela Bio Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

3

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products
Pipeline
Inebilizumab:
a Humanized Monoclonal Antibody
XXX
XXX
XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More
Image for loader

Competitor Comparison

Key Parameters Viela Bio Inc AnTolRx Inc AstraZeneca Pharmaceuticals LP Crescendo Bioscience Inc Genentech USA Inc
Headquarters United States of America United States of America United States of America United States of America United States of America
City Gaithersburg Cambridge Gaithersburg San Francisco South San Francisco
State/Province Maryland Massachusetts Maryland California California
No. of Employees 170 - - - 14,000
Entity Type Private Private Private Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Executives
Name Position Board Since Age
Bing Yao, Ph.D. Director; Chairman; Chief Executive Officer Executive Board - 54
Mitchell Chan Chief Financial Officer Senior Management - 39
Jorn Drappa, MD, Ph.D. Chief Medical Officer; Head - Research and Development Senior Management - 55
Maureen Menacher Vice President; Head - Market Access Senior Management - -
Aaron Ren, Ph.D. Head - Business Development and Operations; Vice President Senior Management - 43
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer